SPG20

Last updated
SPART
Protein SPG20 PDB 2dl1.png
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases SPART , SPARTIN, TAHCCP1, SPG20, spastic paraplegia 20 (Troyer syndrome)
External IDs OMIM: 607111 HomoloGene: 32243 GeneCards: SPART
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001142294
NM_001142295
NM_001142296
NM_015087

n/a

RefSeq (protein)

n/a

Location (UCSC) Chr 13: 36.3 – 36.37 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Spartin is a protein that in humans is encoded by the SPG20 gene. [3] [4] [5]

Contents

This gene encodes a protein that contains a MIT (Microtubule Interacting and Trafficking molecule) domain. This protein may be involved in endosomal trafficking, microtubule dynamics, or both functions. Spartin loss has been associated to mitochondrial dysfunction, impaired complex I activity and altered pyruvate metabolism. [6] Frameshift mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [5] Troyer syndrome (SPG20) is a complicated type of hereditary spastic paraplegias (HSPs). [7] HSP is a category of neurological disorder characterized by spasticity and muscle weakness in the lower limbs. [7]

Background

The original description of this gene mutation and associated symptoms were described in 1967. [8] This mutation is commonly found in high frequency with the Amish population. [4] Newer studies have found that the mutation is not isolated to the Amish population, but also resides in the Omani population. [8]

Presentation

This syndrome is not only characterized by spasticity and weakness in the lower limbs, but also with dysarthria, mental retardation or mild developmental delay, and muscle wasting or muscle atrophy. [7]

Physical

Individuals appear to have difficulty walking, and report a clumsy, spastic gait which worsens over time. [8] Some additional common physical features include overgrowth of the jaw bone, hammer toes, hand and feet abnormalities, and pes cavus. [8]

Cognitive

Cognitive challenges, including developmental delay and difficulty with performance in school, may affect individuals with this syndrome. [8]

Neurologic

Neurologic examination of individuals with this mutation may show dysmetria in the upper extremities, hyperreflexia, distal amyotrophy and ankle clonus, in addition to spasticity, weakness and dysarthria. [8]

Diagnostic Imaging

The cerebellar vermis may present with mild atrophy and a loss of white matter volume. [8]

Through Lifespan

Facial dysmorphism and subtle skeletal features are common in younger children. [8] The condition progressively worsens, as spasticity and distal amyotrophy symptoms are revealed more in teenage years. [8] SPG20 expression in the adult is relatively modest, however it is widespread in the nervous system. [8] Longitudinal comparison of magnetic resonance imaging concluded that there was a progression of the syndrome; thus, the condition appears to worsen over time. [8]

Related Research Articles

Hereditary spastic paraplegia (HSP) is a group of inherited diseases whose main feature is a progressive gait disorder. The disease presents with progressive stiffness (spasticity) and contraction in the lower limbs. HSP is also known as hereditary spastic paraparesis, familial spastic paraplegia, French settlement disease, Strumpell disease, or Strumpell-Lorrain disease. The symptoms are a result of dysfunction of long axons in the spinal cord. The affected cells are the primary motor neurons; therefore, the disease is an upper motor neuron disease. HSP is not a form of cerebral palsy even though it physically may appear and behave much the same as spastic diplegia. The origin of HSP is different from cerebral palsy. Despite this, some of the same anti-spasticity medications used in spastic cerebral palsy are sometimes used to treat HSP symptoms.

<span class="mw-page-title-main">Proteolipid protein 1</span> Type of myelin-associated protein

Proteolipid protein 1 (PLP1) is a form of myelin proteolipid protein (PLP). Mutations in PLP1 are associated with Pelizaeus–Merzbacher disease. It is a 4 transmembrane domain protein which is proposed to bind other copies of itself on the extracellular side of the membrane. In a myelin sheath, as the layers of myelin wraps come together, PLP will bind itself and tightly hold the cellular membranes together.

<span class="mw-page-title-main">Spastin</span> Protein

The human gene SPAST codes for the microtubule-severing protein of the same name, commonly known as spastin.

Atlastin-1, is a protein that in humans is encoded by the ATL1 gene.

<span class="mw-page-title-main">BSCL2</span> Protein-coding gene in the species Homo sapiens

Seipin is a protein that in humans is encoded by the BSCL2 gene.

<span class="mw-page-title-main">MKKS</span> Protein-coding gene in the species Homo sapiens

McKusick–Kaufman/Bardet–Biedl syndromes putative chaperonin is a protein that in humans is encoded by the MKKS gene.

<span class="mw-page-title-main">Paraplegin</span> Protein-coding gene in the species Homo sapiens

Paraplegin is a protein that in humans is encoded by the SPG7 gene located on chromosome 16.

<span class="mw-page-title-main">KIF5A</span> Protein-coding gene in humans

Kinesin family member 5A is a protein that in humans is encoded by the KIF5A gene. It is part of the kinesin family of motor proteins.

<span class="mw-page-title-main">NIPA1</span> Protein-coding gene in humans

Non-imprinted in Prader-Willi/Angelman syndrome region protein 1 is a protein that in humans is encoded by the NIPA1 gene. This gene encodes a potential transmembrane protein which functions either as a receptor or transporter molecule, possibly as a magnesium transporter. This protein is thought to play a role in nervous system development and maintenance. Alternative splice variants have been described, but their biological nature has not been determined. Mutations in this gene have been associated with the human genetic disease autosomal dominant spastic paraplegia 6.

<span class="mw-page-title-main">KIAA0196</span> Protein-coding gene in the species Homo sapiens

KIAA0196 is a human gene. The product is a protein that is a component of the WASH complex, which regulates actin assembly on intracellular vesicles. Mutations in KIAA0196 are implicated in some forms of hereditary spastic paraplegia.

<span class="mw-page-title-main">KIF1C</span> Protein-coding gene in the species Homo sapiens

Kinesin-like protein KIF1C is a protein that in humans is encoded by the KIF1C gene. Kif1C is a fast, plus-end directed microtubule motor. It takes processive 8nm steps along microtubules and can generate forces of up to 5 pN. Kif1C transports α5β1-integrins in human cells. Kif1C has been shown to be non-essential in mouse with other proteins able to perform the same function. However, mutations in KIF1C lead to spastic paraplegia and cerebellar dysfunction in humans. These mutations usually result in a total loss of the protein or (partial) loss of function, such as significant lower force output.

<span class="mw-page-title-main">SPG21</span> Protein-coding gene in the species Homo sapiens

Maspardin is a protein that in humans is encoded by the SPG21 gene.

<span class="mw-page-title-main">REEP1</span> Protein-coding gene in the species Homo sapiens

Receptor expression-enhancing protein 1 is a protein that in humans is encoded by the REEP1 gene.

Warburg Micro syndrome (WARBM), also known as Spastic Paraplegia 69 (SPG69) or RAB18 Deficiency, is a rare autosomal recessive genetic disorder characterized by congenital cataract, hypotonia, spastic diplegia, intellectual or developmental disability, microcephaly, microcornea, optic atrophy, and hypogenitalism.

<span class="mw-page-title-main">FARS2</span> Protein-coding gene in the species Homo sapiens

Phenylalanyl-tRNA synthetase, mitochondrial (FARS2) is an enzyme that in humans is encoded by the FARS2 gene. This protein encoded by FARS2 localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 14, also known as Alpers encephalopathy, as well as spastic paraplegia 77 and infantile-onset epilepsy and cytochrome c oxidase deficiency.

<span class="mw-page-title-main">SPG11</span>

Spatacsin is a protein that in humans is encoded by the SPG11 gene.

<span class="mw-page-title-main">ZFYVE26</span> Protein-coding gene in the species Homo sapiens

Zinc finger, FYVE domain containing 26 is a protein that in humans is encoded by the ZFYVE26 gene.

Spastic paraplegia 15 (SPG15) is a form of hereditary spastic paraplegia that commonly becomes apparent during childhood or adolescence. The disease is caused by mutations within the ZFYVE26 gene - also known as the SPG15 gene - and is passed down in an autosomal recessive manner.

<span class="mw-page-title-main">AP5B1</span> Protein-coding gene in the species Homo sapiens

AP-5 complex subunit beta (AP5B1) is a protein that in humans is encoded by the AP5B1 gene.

<span class="mw-page-title-main">AP5S1</span> Protein-coding gene in the species Homo sapiens

AP-5 complex subunit sigma (AP5S1) is a protein that in humans is encoded by the AP5S1 gene.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000133104 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Cross HE, McKusick VA (Jun 1967). "The Troyer syndrome. A recessive form of spastic paraplegia with distal muscle wasting". Arch Neurol. 16 (5): 473–85. doi:10.1001/archneur.1967.00470230025003. PMID   6022528.
  4. 1 2 Patel H, Cross H, Proukakis C, Hershberger R, Bork P, Ciccarelli FD, Patton MA, McKusick VA, Crosby AH (Jul 2002). "SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia". Nat Genet. 31 (4): 347–8. doi:10.1038/ng937. PMID   12134148. S2CID   23051225.
  5. 1 2 "Entrez Gene: SPG20 spastic paraplegia 20, spartin (Troyer syndrome)".
  6. Chiara Diquigiovanni; Christian Bergamini; Rebeca Diaz; Irene Liparulo; Francesca Bianco; Luca Masin; Vito Antonio Baldassarro; Nicola Rizzardi; Antonia Tranchina; Francesco Buscherini; Anita Wischmeijer; Tommaso Pippucci; Emanuela Scarano; Duccio Maria Cordelli; Romana Fato; Marco Seri; Silvia Paracchini; Elena Bonora (7 August 2019). "A novel mutation in SPART gene causes a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and altered pyruvate metabolism". FASEB Journal. 33 (10): 11284–11302. doi: 10.1096/fj.201802722R . PMID   31314595.
  7. 1 2 3 Bakowska, J.C.; Jenkins, R.; Pendleton, J.; Blackstone, C. (2005). "The Troyer syndrome (SPG20) protein interacts with Eps15". Biochemical and Biophysical Research Communications. 334 (4): 1042–1048. doi:10.1016/j.bbrc.2005.06.201. PMID   16036216.
  8. 1 2 3 4 5 6 7 8 9 10 11 Manzini, M. C.; Rajab, A.; Maynard, T. M.; Mochida, G. H.; Tan, W.; Nasir, R.; et al. (2010). "Developmental and degenerative features in a complicated spastic paraplegic". Annals of Neurology. 67 (4): 516–525. doi:10.1002/ana.21923. PMC   3027847 . PMID   20437587.

Further reading